Florida Senate - 2007                        SENATOR AMENDMENT
    Bill No. HB 1155, 2nd Eng.
                        Barcode 190244
                            CHAMBER ACTION
              Senate                               House
                                   .                    
                                   .                    
 1                                 .                    
                                   .                    
 2                                 .                    
                                   .                    
 3         Floor: WD/2R            .                    
       05/02/2007 05:01 PM         .                    
 4  ______________________________________________________________
 5  
 6  
 7  
 8  
 9  
10  ______________________________________________________________
11  Senator Saunders moved the following amendment to amendment
12  (461802):
13  
14         Senate Amendment (with title amendment) 
15         On page 7, between lines 22 and 23,
16  
17  insert:  
18         Section 4.  Section (53) is added to section 409.912,
19  Florida Statutes, to read:
20         409.912  Cost-effective purchasing of health care.--The
21  agency shall purchase goods and services for Medicaid
22  recipients in the most cost-effective manner consistent with
23  the delivery of quality medical care. To ensure that medical
24  services are effectively utilized, the agency may, in any
25  case, require a confirmation or second physician's opinion of
26  the correct diagnosis for purposes of authorizing future
27  services under the Medicaid program. This section does not
28  restrict access to emergency services or poststabilization
29  care services as defined in 42 C.F.R. part 438.114. Such
30  confirmation or second opinion shall be rendered in a manner
31  approved by the agency. The agency shall maximize the use of
                                  1
    3:39 PM   05/02/07                           h115502e2c-37-r8y

Florida Senate - 2007 SENATOR AMENDMENT Bill No. HB 1155, 2nd Eng. Barcode 190244 1 prepaid per capita and prepaid aggregate fixed-sum basis 2 services when appropriate and other alternative service 3 delivery and reimbursement methodologies, including 4 competitive bidding pursuant to s. 287.057, designed to 5 facilitate the cost-effective purchase of a case-managed 6 continuum of care. The agency shall also require providers to 7 minimize the exposure of recipients to the need for acute 8 inpatient, custodial, and other institutional care and the 9 inappropriate or unnecessary use of high-cost services. The 10 agency shall contract with a vendor to monitor and evaluate 11 the clinical practice patterns of providers in order to 12 identify trends that are outside the normal practice patterns 13 of a provider's professional peers or the national guidelines 14 of a provider's professional association. The vendor must be 15 able to provide information and counseling to a provider whose 16 practice patterns are outside the norms, in consultation with 17 the agency, to improve patient care and reduce inappropriate 18 utilization. The agency may mandate prior authorization, drug 19 therapy management, or disease management participation for 20 certain populations of Medicaid beneficiaries, certain drug 21 classes, or particular drugs to prevent fraud, abuse, overuse, 22 and possible dangerous drug interactions. The Pharmaceutical 23 and Therapeutics Committee shall make recommendations to the 24 agency on drugs for which prior authorization is required. The 25 agency shall inform the Pharmaceutical and Therapeutics 26 Committee of its decisions regarding drugs subject to prior 27 authorization. The agency is authorized to limit the entities 28 it contracts with or enrolls as Medicaid providers by 29 developing a provider network through provider credentialing. 30 The agency may competitively bid single-source-provider 31 contracts if procurement of goods or services results in 2 3:39 PM 05/02/07 h115502e2c-37-r8y
Florida Senate - 2007 SENATOR AMENDMENT Bill No. HB 1155, 2nd Eng. Barcode 190244 1 demonstrated cost savings to the state without limiting access 2 to care. The agency may limit its network based on the 3 assessment of beneficiary access to care, provider 4 availability, provider quality standards, time and distance 5 standards for access to care, the cultural competence of the 6 provider network, demographic characteristics of Medicaid 7 beneficiaries, practice and provider-to-beneficiary standards, 8 appointment wait times, beneficiary use of services, provider 9 turnover, provider profiling, provider licensure history, 10 previous program integrity investigations and findings, peer 11 review, provider Medicaid policy and billing compliance 12 records, clinical and medical record audits, and other 13 factors. Providers shall not be entitled to enrollment in the 14 Medicaid provider network. The agency shall determine 15 instances in which allowing Medicaid beneficiaries to purchase 16 durable medical equipment and other goods is less expensive to 17 the Medicaid program than long-term rental of the equipment or 18 goods. The agency may establish rules to facilitate purchases 19 in lieu of long-term rentals in order to protect against fraud 20 and abuse in the Medicaid program as defined in s. 409.913. 21 The agency may seek federal waivers necessary to administer 22 these policies. 23 (53)(a) A pharmacist may not dispense a drug for 24 immunosuppressive therapy following transplant unless the drug 25 is the specific formulation and manufactured by the specific 26 manufacturer as prescribed by the patient's physician. 27 (b) A pharmacist may substitute a drug product that is 28 generically equivalent for immunosuppressive therapy following 29 transplant only if, before making the substitution, the 30 pharmacist obtains a signed authorization from the prescribing 31 physician. 3 3:39 PM 05/02/07 h115502e2c-37-r8y
Florida Senate - 2007 SENATOR AMENDMENT Bill No. HB 1155, 2nd Eng. Barcode 190244 1 (c) This subsection does not apply to generic 2 equivalents for immunosuppressive drugs currently on the 3 Medicaid preferred drug list, generic equivalents for 4 immunosuppressive drugs currently under review by the 5 Pharmaceutical and Therapeutics Committee and the agency, or 6 to any patient enrolled in the Medicaid program that is 7 currently receiving generically equivalent immunosuppressive 8 drugs. 9 10 (Redesignate subsequent sections.) 11 12 13 ================ T I T L E A M E N D M E N T =============== 14 And the title is amended as follows: 15 On page 9, line 26, after the semicolon, 16 17 insert: 18 amending s. 409.912, F.S.; providing 19 limitations on the dispensing of certain drugs 20 following transplants; 21 22 23 24 25 26 27 28 29 30 31 4 3:39 PM 05/02/07 h115502e2c-37-r8y